Connect with us

Technology

Onymos and Vanta Diagnostics Collaborate to Scale Intelligent Lab Intake

Published

2 months ago

on

SAN FRANCISCO, Sept. 2, 2026 /PRNewswire/ — Onymos, a leader in intelligent document processing for precision medicine, and Vanta Diagnostics, a leading provider of molecular laboratory services, today announced the results of their collaboration, demonstrating how using AI-assisted intake increased operational efficiency by up to 72%, expanded laboratory capacity by more than 300 samples per day, and reduced accessioning errors by 40%.

Increasingly complex tests, persistent staffing shortages, and evolving payer requirements have made laboratory intake a significant operational bottleneck and source of friction. Errors introduced during this process often cascade into testing delays, billing issues, compliance risks, and preventable rework.

To address these challenges, Onymos and Vanta deployed the Onymos DocKnow intelligent intake platform within Vanta’s accessioning workflow, transforming incoming forms and documents into validated, structured data before being shared with downstream systems.

Following implementation, Vanta realized dramatic gains across multiple metrics, including:

Increasing operational efficiency by up to 72% and reducing requisition processing times to as little as one minute.Expanding laboratory capacity by more than 300 additional samples per day (approximately 6,500 samples per month) while using fewer laboratory personnel.Reducing accessioning errors by 40%, improving data quality, and minimizing downstream rework.

As we were initially evaluating Onymos DocKnow, we saw an opportunity to improve far more than the speed of document processing,” said Mary Katherine DiFilippo, Director of Specimen Analytics at Vanta Diagnostics. “We recognized that by improving the quality of information and how our staff actually processes that information, we could create a much bigger impact.”

“Our mission is to provide rapid results to patients using the most advanced diagnostics,” added Dan Nodes, Chief Operating Officer of Vanta Diagnostics. “Achieving that requires continuous innovation not only in the tests we perform, but in the operational systems that support them. As we continue to grow, investing in intelligent intake helps ensure our operations can scale alongside our science.”

Rather than simply digitizing documents, DocKnow interprets laboratory requisitions and supporting clinical documentation, validates information across multiple sources, and produces enriched outputs that integrate directly with the systems that laboratories already use.

Shiva Nathan, Founder and CEO of Onymos, believes the collaboration proves that “Measurable ROI with AI, not AI for AI’s sake, will define the next generation of precision medicine. In just one quarter, our work with Vanta Diagnostics showed that intelligent intake can not only help laboratories scale, but also unlock improvements in quality, compliance, and turnaround time that were once considered difficult to achieve all at once. Together, we are proving that intake can be a source of competitive advantage.”

Tony Mancuso, Director of Business Development at Onymos, said the results also highlight a broader business reality. “The financial health of a laboratory depends on the quality of the information entering it. Organizations that view intelligent intake as a strategic investment in data quality are better positioned to reduce preventable denials and ultimately drive more revenue.”

Onymos and Vanta Diagnostics are demonstrating a more practical path for AI in the laboratory by moving beyond experimentation and prioritizing measurable outcomes. As other laboratories and healthcare organizations look to maximize the return on technology investments, intelligent intake represents one of the clearest opportunities to turn AI into measurable business value.

About Onymos   
Onymos is transforming manual workflows in healthcare and life sciences. Its DocKnow platform captures, validates, and enriches data from complex documents, enabling organizations to improve data quality at scale, streamline their operations, and drive measurable ROI. To learn more, visit: www.onymos.com. 

About Vanta Diagnostics
Vanta Diagnostics is a national CLIA and CAP-certified laboratory with a dedicated team that provides a comprehensive range of medical diagnostic testing services across 45 states. The company is headquartered in South Carolina with additional laboratories in Pennsylvania and Florida. For more information, please visit vantadiagnostics.com.

Media Contact
Jamie Goodnight
Onymos   
Jamie.goodnight@onymos.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/onymos-and-vanta-diagnostics-collaborate-to-scale-intelligent-lab-intake-302866377.html

SOURCE Onymos

Related Topics:
Continue Reading

Technology

LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do

Published

5 hours ago

on

October 24, 2026

By

Reimagined from the ground up, HumanView pairs statistical modeling with expert analysts to turn millions of real-world customer signals into business decisions

LOUISVILLE, Ky., Oct. 23, 2026 /PRNewswire/ — LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.

HumanView analyzes what customers say and do across social platforms, e-commerce sites, review platforms, search behavior and user-generated content, including signals from Reddit, TikTok, YouTube, Meta, Amazon and Walmart+ that general AI tools cannot always access. Because the data reflects unprompted, real-world behavior, it avoids the response bias built into surveys and focus groups.

The service works in three layers. HumanView captures signals at scale, decodes millions of records through validated statistical models such as regression, correlation and clustering, and then relies on experienced analysts to interpret the patterns. Clients receive clear, human-validated insights instead of another dashboard.

“Machines find the patterns. Humans find the point,” said Alan Gilleo, CEO at LEAP Group. “The first version of HumanView showed us how much customers reveal when nobody is asking them questions. This version is built to explain why they act the way they do, and to put those answers in front of everyone making decisions, from product to service to marketing.”

HumanView focuses on three areas:

Growth Intelligence: customer motivations and how people perceive a brand and its competitors

Market and Category Intelligence: product pain points, service friction, unmet needs and competitive gaps

Audience Intelligence: new segments, positioning opportunities and gaps in the market

Every model is designed and validated by data scientists and benchmarked before it informs a recommendation.

To learn more about HumanView, visit leapgroupnetwork.com/humanview.

About LEAP Group
LEAP Group is a boutique marketing agency holding company with offices in Louisville, Indianapolis, Cincinnati and Chicago. Guided by the belief that brands should “Market Less. Matter More.,” LEAP gives clients access to specialized experts across its entire network. Learn more at leapgroupnetwork.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-group-relaunches-humanview-a-growth-intelligence-system-built-to-explain-why-customers-behave-the-way-they-do-302918557.html

SOURCE LEAP Group

Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

6 hours ago

on

October 24, 2026

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

6 hours ago

on

October 24, 2026

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Trending